NS-050/NCNP-03 in Boys With DMD (Meteor50)

Clinical trial NCT06053814 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06053814
Sponsor: NS Pharma, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Duchenne Muscular Dystrophy

Start date: 2024-09-18
Primary completion: 2028-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.